Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care
Overview of rFVIIa Use for Liver Transplantation
There were four RCTs (two of fair quality, two of poor quality) and one comparative observational study (fair quality) with 215 patients who received prophylactic rFVIIa at initiation of liver transplantation. This yielded low strength of evidence with fair applicability for prophylactic use in the population targeted—patients with cirrhosis of Child’s class B or C. There was no effect of rFVIIa use on mortality or thromboembolism relative to usual care. There was a trend across studies toward reduced RBC transfusion requirements with rFVIIa use vs. usual care. Neither operating room time nor ICU length of stay were reduced with rFVIIa use when compared to usual care. Current evidence of low strength is too limited to compare harms and benefits.
- Hendriks HG, Meijer K, de Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 2001;71:402-5.
- Liu JP, Chen T, Wang J, et al. Hemorrhagic features and the application of recombinant activated factor VII in liver transplantation. J Clin Rehabil Tissue Eng Res 2009;13:3580-4.
- Lodge JPA, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transplant 2005;11:973-9.
- Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transplant 2005;11:895-900.
- Pugliese F, Ruberto F, Summonti D, et al. Activated recombinant factor VII in orthotopic liver transplantation. Transplant Proc 2007;39:1883-5.
- Yank V, Tuohy CV, Logan AC, et al. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care, Comparative Effectiveness Review 21 (Prepared by Stanford–UCSF Evidence-based Practice Center under Contract No. 290-02-0017). Rockville, MD: Agency for Healthcare Research and Quality; May 2010. AHRQ Publication No. 10-EHC030-EF.
Your slide tray is being processed.